SCHEMBL12469564

SCHEMBL12469564

CCNC(=O)Nc1nc2c[c]cc(C(=O)NCC)c2s1

nearest known ligand 0.52

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
ABL1 P00519 10/20 0.46
PIK3CA P42336 1/20 0.42
PIK3CG P48736 1/20 0.42
PIK3CD O00329 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1708656 0.80 NPC1 (0.52) NPC1RAB9ASMN1; SMN2ABL1PIK3CA
SCHEMBL1283007 0.80 NPC1 (0.52) NPC1RAB9ASMN1; SMN2ABL1PIK3CA
SCHEMBL1282966 0.79 ABL1 (0.56) NPC1RAB9ASMN1; SMN2ABL1PIK3CA
SCHEMBL1292161 0.76 NPC1 (0.46) NPC1RAB9ASMN1; SMN2ABL1PIK3CA
SCHEMBL28805227 0.75 NPC1 (0.67) NPC1RAB9ASMN1; SMN2ABL1PIK3CA
SCHEMBL12469561 0.75 NPC1 (0.32) NPC1
SCHEMBL12469595 0.75 NPC1 (0.56) NPC1RAB9ASMN1; SMN2ABL1
SCHEMBL1708003 0.72 NPC1 (0.52) NPC1RAB9ASMN1; SMN2ABL1PIK3CA
SCHEMBL220748 0.71 ABL1 (0.52) ABL1
SCHEMBL1282103 0.71 ABL1 (0.43) NPC1RAB9ASMN1; SMN2ABL1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012047703-A2 CYCLOPROPYL-SPIRO-PIPERIDINES USEFUL AS SODIUM CHANNEL BLOCKERS SCHERING CORPORATION (US) 2012-04-12 WO claimed
EP-2625178-A1 BACTERIA TOPOISOMERASE II INHIBITING 2-ETHYLCARBAMOYLAMINO-1, 3-BENZOTHIAZOL-5-YLS Biota Europe Ltd (GB) 2013-08-14 EP disclosed
WO-2012045124-A1 BACTERIA TOPOISOMERASE II INHIBITING 2-ETHYLCARBAMOYLAMINO-1, 3-BENZOTHIAZOL-5-YLS BIOTA EUROPE LTD (GB) 2012-04-12 WO disclosed